News about Market

ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals launches Carbamazepine extended-release capsules, a generic version of Carbatrol.

Market | 13/04/2026 | By News Bureau |  101

IASO Biotechnology Partners with Instituto Butantan to Localise CAR-T Therapy in Brazil

IASO Bio licenses CAR-T technology to Instituto Butantan for local development in Brazil, aiming to reduce treatment costs and expand public access to advanced therapies for haematological cancer patients.

Market | 13/04/2026 | By News Bureau |  162

Croma-Pharma Acquires Synocrom, Re-Enters Orthopaedics

Croma-Pharma acquires Synocrom to re-enter orthopaedics, expanding its portfolio with a hyaluronic acid treatment for knee osteoarthritis launching in the EU and Switzerland in May 2026.

Market | 10/04/2026 | By News Bureau |  168

Forte Biosciences Announces Pricing of USD 150 Million Public Offering

Forte Biosciences announces pricing of its USD 150 million public offering, with expected gross proceeds of USD 150 million before underwriting discounts, commissions, and offering expenses.

Market | 10/04/2026 | By News Bureau |  101

Amazon Pharmacy to Deliver Foundayo Same-Day, Expanding Access to Eli Lilly's New GLP-1 Pill

Amazon Pharmacy now offers Eli Lilly’s GLP-1 pill Foundayo with real-time availability, transparent pricing from USD 1/day with insurance, USD 5/day cash, and automatic manufacturer-sponsored coupons—soon via in-office kiosks within minutes.

Market | 09/04/2026 | By News Bureau |  226

Merck Starts Tender Offer to Buy Terns Pharmaceuticals

Merck launches a tender offer to acquire Terns Pharmaceuticals, with plans to make it a wholly owned subsidiary.

Market | 08/04/2026 | By News Bureau |  148

MedGenome Study Highlights Role of RNA-Based NGS in Improving Sarcoma Diagnosis in India

India’s first prospective study finds that RNA sequencing enhances diagnostic accuracy and influences treatment decisions in complex sarcoma cases, supporting precision oncology in resource-limited settings.

Market | 08/04/2026 | By News Bureau

Gilead Expands Oncology Pipeline with Tubulis Acquisition

Gilead to acquire Tubulis, adding TUB-040 ADC for ovarian cancer and a next-generation platform with Tubutecan technology, strengthening its oncology pipeline and ADC capabilities.

Market | 08/04/2026 | By News Bureau

Bayer Updates Access Model for Eylea 2mg in India

Bayer revises its access model for Eylea 2mg in India to expand patient eligibility and reduce upfront costs, enabling earlier treatment for retinal diseases.

Market | 08/04/2026 | By News Bureau

Biocon Launches Bosaya and Aukelso Denosumab Biosimilars in US

Biocon launches Bosaya and Aukelso denosumab biosimilars in the US following FDA approval with interchangeable status, expanding treatment options for osteoporosis and bone metastasis patients.

Market | 08/04/2026 | By News Bureau |  120